Victory Capital Management’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Victory Capital Management's CABA Position: Q3 2026 in Review
Victory Capital Management reduced its Cabaletta Bio (CABA) stake by 7.7% in Q3 2026, selling an estimated $3.57K and leaving 15,223 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2473.
Victory Capital Management first reported a position in CABA in Q4 2019 and has held it in 20 quarters since. The position peaked at $9.17M in Q4 2023. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Victory Capital Management held 15,223 shares of Cabaletta Bio worth $29.2K as of Q3 2026.
- Victory Capital Management sold 1,267 Cabaletta Bio shares in Q3 2026, an estimated $3.57K.
- Cabaletta Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2473 holding.
- Victory Capital Management first reported a position in Cabaletta Bio in Q4 2019 and has held it in 20 quarters since.
- Victory Capital Management's Cabaletta Bio position peaked at $9.17M in Q4 2023.
- 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.